Welcome to our dedicated page for U S Physical Therapy SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how clinic visit volumes, payer mix, and therapist partnership incentives shape U.S. Physical Therapy’s cash flow can feel overwhelming. When reimbursement tables are buried deep inside a 300-page report, even seasoned analysts struggle to find answers—especially if they just want U.S. Physical Therapy SEC filings explained simply.
StockTitan solves that problem. Our AI reads every U.S. Physical Therapy annual report 10-K simplified, flags changes in segment margins inside each U.S. Physical Therapy quarterly earnings report 10-Q filing, and streams U.S. Physical Therapy Form 4 insider transactions real-time. Need context on an unexpected acquisition? We surface the corresponding U.S. Physical Therapy 8-K material events explained alongside plain-English summaries. Prefer raw numbers? Download exhibits without digging through EDGAR.
- Instant alerts for U.S. Physical Therapy insider trading Form 4 transactions
- Side-by-side comparison of clinic metrics across quarters—perfect for U.S. Physical Therapy earnings report filing analysis
- Highlights of salary, bonus, and option grants pulled from the latest U.S. Physical Therapy proxy statement executive compensation
- Contextual pop-ups that make understanding U.S. Physical Therapy SEC documents with AI effortless
Whether you’re monitoring U.S. Physical Therapy executive stock transactions Form 4 before a new clinic rollout or checking covenant compliance after a debt refinancing, our real-time feed and AI-powered summaries give you the insight you need—without wading through endless footnotes.
U.S. Physical Therapy, Inc. reported that it has acquired a 50% interest in a physical therapy management services company. This business exclusively manages a physical therapy practice with eight clinic locations, generating approximately
The transaction expands U.S. Physical Therapy’s presence in outpatient physical therapy and industrial injury prevention services by adding an established, revenue-generating group of clinics to its network.
U.S. Physical Therapy, Inc. (USPH) filed a Form 4 reporting an insider stock sale by its COO. On 11/24/2025, the reporting officer sold 743 shares of common stock in an open market transaction at a weighted average price of $71.01 per share, with individual trade prices ranging from $71.01 to $71.31.
After this transaction, the officer beneficially owns 20,740 shares directly and 1,808 shares indirectly through the Reeve Trust. The filing notes that 13,348 of these shares were granted as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan, with portions scheduled to vest in installments between March 2026 and March 2029, contingent on continued employment.
U.S. Physical Therapy, Inc. (USPH) director reported a purchase of company stock. On 11/20/2025, the reporting person bought 4,000 shares of common stock at a price of $69 per share, coded as a purchase transaction on a Form 4 filing. After this trade, the director beneficially owns 24,786 shares directly.
This total includes 471 restricted shares that were granted under the company’s Amended and Restated 2003 Stock Incentive Plan. These restricted shares will fully vest on March 6, 2026, provided she continues to serve on the Board of Directors through that date.
U.S. Physical Therapy (USPH) insider Graham Reeve has filed a Form 144 to sell 743 shares of common stock. The proposed sale has an aggregate market value of $52,761.58 and is planned for 11/21/2025 on the NYSE through J.P. Morgan Securities LLC. Shares outstanding were 15,204,119, providing context for the size of the planned sale. The shares to be sold relate to equity compensation, as 1,948 common shares were acquired on 11/21/2025 through the vesting of restricted stock grants issued between 08/16/2021 and 02/24/2025 as payment for services. In the prior three months, Reeve sold 763 common shares on 08/21/2025 for gross proceeds of $64,832.11. The signer represents that they are not aware of undisclosed material adverse information about the company’s operations.
U.S. Physical Therapy, Inc.
The updated presentation is being shared under a Regulation FD disclosure, meaning it is intended to provide fair and equal access to information for all investors. The materials are furnished rather than filed, so they are not automatically incorporated into other securities law filings unless specifically referenced.
U.S. Physical Therapy, Inc. furnished a conference call transcript as Exhibit 99.1 under Item 7.01 (Regulation FD). The call, held on November 6, 2025, discussed results for the three and nine months ended September 30, 2025.
The company states the information is furnished, not filed, is not subject to Section 18 of the Exchange Act, and will not be incorporated by reference into Securities Act or Exchange Act filings except as expressly set forth by specific reference.
U.S. Physical Therapy (USPH) reported stronger Q3 2025 results. Net revenue rose to
Operating income improved to
The company ended the quarter with cash of
U.S. Physical Therapy, Inc. reported results for the three and nine months ended September 30, 2025, and attached a press release as Exhibit 99.1.
The Board declared a quarterly dividend of $0.45 per share, payable on December 12, 2025, to shareholders of record on November 17, 2025.
U.S. Physical Therapy, Inc. (USPH) received a Schedule 13G from Copeland Capital Management, LLC disclosing beneficial ownership of 843,981 shares, representing 5.54% of the common stock as of 09/30/2025.
The filer reports sole voting power over 551,532 shares, shared voting power over 144,267 shares, sole dispositive power over 0 shares, and shared dispositive power over 843,981 shares. The reporting person is classified as an investment adviser (IA). The certification and signature were provided by Sofia A. Rosala, General Counsel and CCO.
Nancy Ham, a director of U S Physical Therapy, reported selling 600 shares of the company's common stock on 09/11/2025 at $81.71 per share. After the sale she beneficially owns 1,994 shares in total. That total includes 941 restricted shares granted under the company's Amended and Restated 2003 Stock Incentive Plan, with 470 shares scheduled to lapse (vest) on November 20, 2025 and 471 shares scheduled to lapse on March 6, 2026, subject to her continuing service as a director on those dates.
FAQ
What is the current stock price of U S Physical Therapy (USPH)?
What is the market cap of U S Physical Therapy (USPH)?
